Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 140 participants.
Also called NCT07511361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 140 participants
- Sponsor
- Registry
-
NCT07511361
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07511361. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-23 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Acronym
- KARDINAL-ASH
- Condition
- Hypertension
- Condition
- Acute Severe Hypertension
- Condition
- Hypertensive Emergency
- Condition
- Hypertensive Urgency
- Intervention (Drug)
- Tonlamarsen
- Intervention (Drug)
- Placebo
- Lead sponsor
- Kardigan, Inc.
Record details
- Record id
cardio:ct-nct07511361- Content hash
32ee363b5077adf50e7376403ee97eaf42b2d856e01015b3a1b42ea28b7a3212